PKM1 is constitutively activated and expressed in terminally differentiated tissues to promote oxidative phosphorylation, whereas PKM2 is highly expressed in embryonic and cancer cells, which is an allosteric isoform and exhibits a dimer with low affinity for PEP. This evidence concerns the gene PKM and cancer.